<?xml version="1.0" encoding="utf-8" ?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Saurabhsharma71 - Latest News</title>
<link href="https://news.prfree.org/rss/saurabhsharma71/latest.xml"></link>
<updated>2026-08-20T01:25:44+00:00</updated>
<id>urn:uuid:16a2962d-44f4-647c-45b6-ed924f1bb77d</id>
<entry>
<title>DA Approves Tablet Form of Zanubrutinib for All Approved Indications</title>
<link href="https://prfree.org/news-da-approves-tablet-form-of-zanubrutinib-for-all-approved-indications-7877b4zh.html"></link>
<id>urn:uuid:06f7c6d5-b29f-3c26-7019-af68427601a6</id>
<summary type="html"><![CDATA[New formulation provides patients with a simplified dosing experience—reducing pill burden and enhancing ease of administration—while preserving flexible dosing options]]></summary>
<updated>2026-08-19T22:13:48+00:00</updated>
</entry>
</feed>